Literature DB >> 33732562

Autoimmune Encephalitis in Children: From Suspicion to Diagnosis.

Kam Lun Ellis Hon1, Alexander K Leung2, Cheuk Chung Au3, Alcy R Torres4.   

Abstract

There are several well-described and studied autoimmune diseases that affect different organ systems, and a limited number of these affect the central nervous system. Autoimmune encephalitis represents a disease with a wide spectrum of clinical manifestations and different levels of severity, from mild cognitive impairment to complex encephalopathy. Immune-mediated encephalitis refers to a diverse and rare group of conditions in children associated with nonspecific symptomatology, altered mental state, and recalcitrant seizures. Infectious etiology must be excluded. Immune-mediated encephalitis syndromes could be associated with paraneoplastic or primarily autoimmune mechanisms. The newest scientific advantages have concluded that autoimmune encephalitis may be further divided into different groups of diseases depending on the immune response; examples are antibodies to cell surface proteins, antibodies to intracellular synaptic proteins, T-cell response with antibodies to intracellular antigens, among others. Treatment consists of supportive therapy, ranging from supplemental oxygen, fluid restriction to mechanical circulatory support. Specific treatment includes immunoglobulin infusion, plasmapheresis, and pulse steroid treatment. Prognosis is poor if specific treatment is not timely instituted. The diagnosis of autoimmune encephalitis could be challenging to clinicians due to its diverse clinical features, which can mimic a variety of other pathologic processes. Screening for cancer and proper management that includes immune therapy are fundamental, although some patients will need immune suppression for weeks or months as autoimmune encephalitis may relapse; therefore, follow-up is always necessary.
Copyright © 2021, Hon et al.

Entities:  

Keywords:  autoantibodies; autoimmune encephalitis; paraneoplastic encephalitis syndromes

Year:  2021        PMID: 33732562      PMCID: PMC7955954          DOI: 10.7759/cureus.13307

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  33 in total

Review 1.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

Review 2.  Autoimmune encephalopathies.

Authors:  Frank Leypoldt; Thaís Armangue; Josep Dalmau
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

3.  Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy.

Authors:  Suvi Liimatainen; Jukka Peltola; Aki Hietaharju; Lidia Sabater; Bethan Lang
Journal:  Epilepsy Res       Date:  2014-01-06       Impact factor: 3.045

4.  Autoimmune encephalitis management: MS centers and beyond.

Authors:  Andrew McKeon; Anastasia Zekeridou
Journal:  Mult Scler       Date:  2020-02-13       Impact factor: 6.312

5.  Successful combination immunotherapy of anti-gamma aminobutyric acid (GABA)A receptor antibody-positive encephalitis with extensive multifocal brain lesions.

Authors:  Yuki Fukami; Hiroaki Okada; Mari Yoshida; Keiji Yamaguchi
Journal:  Rinsho Shinkeigaku       Date:  2017-07-22

6.  Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch
Journal:  Ann Neurol       Date:  2007-01       Impact factor: 10.422

7.  Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome.

Authors:  Sekhar C Pillai; Yael Hacohen; Esther Tantsis; Kristina Prelog; Vera Merheb; Alison Kesson; Elizabeth Barnes; Deepak Gill; Richard Webster; Manoj Menezes; Simone Ardern-Holmes; Sachin Gupta; Peter Procopis; Christopher Troedson; Jayne Antony; Robert A Ouvrier; Yann Polfrit; Nicholas W S Davies; Patrick Waters; Bethan Lang; Ming J Lim; Fabienne Brilot; Angela Vincent; Russell C Dale
Journal:  Pediatrics       Date:  2015-04       Impact factor: 7.124

8.  Neuropsychiatric and seizure outcomes in nonparaneoplastic autoimmune limbic encephalitis.

Authors:  Rani A Sarkis; Romy Nehme; Zeina N Chemali
Journal:  Epilepsy Behav       Date:  2014-08-24       Impact factor: 2.937

9.  Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.

Authors:  A Venkatesan; A R Tunkel; K C Bloch; A S Lauring; J Sejvar; A Bitnun; J-P Stahl; A Mailles; M Drebot; C E Rupprecht; J Yoder; J R Cope; M R Wilson; R J Whitley; J Sullivan; J Granerod; C Jones; K Eastwood; K N Ward; D N Durrheim; M V Solbrig; L Guo-Dong; C A Glaser
Journal:  Clin Infect Dis       Date:  2013-07-15       Impact factor: 9.079

Review 10.  The Laboratory Diagnosis of Autoimmune Encephalitis.

Authors:  Sang Kun Lee; Soon-Tae Lee
Journal:  J Epilepsy Res       Date:  2016-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.